Kohji Yamada et al. showed that E-syt1 contributes to the growth of hepatocellular carcinoma cells and that it may also be a therapeutic target for hepatocellular carcinoma [42]. This evidence concerns the gene ESYT1 and hepatocellular carcinoma.